drugset / Trial / NCT02274428
Phase 1 Clinical Trial of PNEUMOSTEM® Treatment in Premature Infants With Intraventricular Hemorrhage
NaSingle-groupOpen-labelTreatment
Summary
Phase 1 clinical trial for the safety and dose determination of Pneumostem (human umbilical cord blood derived mesenchymal stem cells) in the premature infants with intraventricular hemorrhage (IVH, grade 3-4)
Timeline
- Start
- 2014-10
- Primary completion
- 2016-02
- Completion
- 2016-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | PNEUMOSTEM® | Cell therapy | — | — |
Indications
No indication recorded.